Arbutus Biopharma ABUS
NASDAQ ABUS
$4.45 -0.11 (-2.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Other Accumulated Expenses (2013 - 2015)

Updated

Arbutus Biopharma (ABUS) recorded Other Accumulated Expenses of $745,000 in Q2 2015, up 169.9% from $276,000 a year earlier but down 40.4% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Other Accumulated Expenses (2013 - 2015) Analysis & Trends

At the end of FY2014, Arbutus Biopharma reported Other Accumulated Expenses of $226,000, down 71.6% from FY2013.

  • Across earlier years, Other Accumulated Expenses came in at $795,000 in FY2013.
  • Quarterly Other Accumulated Expenses has ranged from $226,000 in Q4 2014 to $1.25 million in Q1 2015 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.25 million (Q1 2015), $226,000 (Q4 2014) and $418,000 (Q3 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Arbutus Biopharma 901.21 Mn 528.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 745,000.00
Mar 31, 2015 1.25 Mn
Dec 31, 2014 226,000.00
Sep 30, 2014 418,000.00
Jun 30, 2014 276,000.00
Mar 31, 2014 510,000.00
Dec 31, 2013 795,000.00
API Access

Arbutus Biopharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY